Specialty Pharmaceuticals Industry Financials, Performance and Ratios
-
Industry Score
37.3 /100
Rank 102 out of 131 Industries -
Advance/Decline
8/16
-
No. of Companies24
-
Avg. Market Cap1,915
-
Price to Earning Ratio31.21
-
Price to Earning Growth Ratio0.10
-
Price to Book Ratio6.20
-
Return on Equity16.98
-
Return on Capital Employed-
-
Return on Assets14.92
-
Dividend yield 1 year %0.00
-
Net Profit Growth Annual YoY %86.82 %
-
Net Profit Growth Qtr YoY %56.29 %
-
Net Profit Growth Qtr QoQ %-109.78 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Specialty Pharmaceuticals Industry Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Specialty Pharmaceuticals Peer comparison
Compare all stocks in Specialty Pharmaceuticals industry listed on stock exchanges
Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
---|---|---|---|---|---|---|---|---|---|---|---|
Usana Health Sciences Inc |
|
583.3
|
31.3
|
L
 -3.9%
H
31.3
32.7
|
L
 -2.5%
H
31.3
33.9
|
L
 6.0%
H
29.6
33.9
|
L
 27.9%
H
23.1
33.9
|
L
 -30.9%
H
23.1
48.9
|
L
 -51.9%
H
23.1
73.3
|
L
 -63.2%
H
23.1
107.9
|
L
 -54.1%
H
23.1
138.0
|
Argen X SE - ADR |
|
34,024.7
|
556.0
|
L
 -1.0%
H
554.6
568.2
|
L
 1.8%
H
536.0
572.0
|
L
 -3.8%
H
510.1
574.6
|
L
 -8.3%
H
510.1
657.4
|
L
 19.2%
H
457.4
678.2
|
L
 54.5%
H
327.7
678.2
|
L
 118.7%
H
212.7
678.2
|
L
H
17.3
678.2
|
Biondvax Pharmaceuticals L... |
|
-
|
2.2
|
L
 -3.5%
H
2.2
2.4
|
L
 3.3%
H
2.1
2.5
|
L
H
2.1
2.9
|
L
 -23.7%
H
2.1
6.2
|
L
 -23.7%
H
2.1
6.2
|
L
 -82.0%
H
0.6
99
|
L
 -99.5%
H
0.6
499.0
|
L
 -95.1%
H
0.6
620
|
Cidara Therapeutics Inc |
|
1,139.1
|
51.5
|
L
 -6.9%
H
50.9
55.3
|
L
 6.6%
H
45.9
55.8
|
L
 125.5%
H
20.2
56.8
|
L
 174.8%
H
18.5
56.8
|
L
 348.6%
H
10.1
56.8
|
L
 -83.0%
H
10
840
|
L
 -96.4%
H
10
1736
|
L
 -99.1%
H
10
7228
|
Niagen Bioscience Inc. |
|
872.8
|
11.1
|
L
 -1.6%
H
11.0
11.4
|
L
 -10.9%
H
11.0
12.6
|
L
 -18.7%
H
11.0
14.7
|
L
 80.5%
H
6.1
14.7
|
L
 324.5%
H
2.5
14.7
|
L
 522.5%
H
1.2
14.7
|
L
 121.6%
H
1.2
23.7
|
L
 232.7%
H
1.2
23.7
|
Cronos Group Inc |
|
778.5
|
2.0
|
L
 -2.4%
H
2.0
2.1
|
L
 -1.0%
H
2.0
2.2
|
L
 4.7%
H
1.8
2.2
|
L
 17.4%
H
1.7
2.2
|
L
 -16.2%
H
1.6
2.5
|
L
 -35.3%
H
1.6
3.6
|
L
 -68.4%
H
1.6
15.8
|
L
H
0.2
25.1
|
Enveric Biosciences Inc |
|
3.0
|
1.2
|
L
 -8.2%
H
1.2
1.3
|
L
 -3.2%
H
1.2
1.4
|
L
 1.7%
H
1.2
1.4
|
L
 -3.2%
H
1.1
1.5
|
L
 136.5%
H
0.3
4.8
|
L
 -85.1%
H
0.3
14.9
|
L
 -99.7%
H
0.3
752
|
L
 -100.0%
H
0.3
67500
|
Flora Growth Corp |
|
15.1
|
0.7
|
L
 -2.9%
H
0.6
0.7
|
L
 15.5%
H
0.6
0.7
|
L
 -9.5%
H
0.6
0.8
|
L
 45.7%
H
0.4
0.8
|
L
 -38.0%
H
0.4
2.1
|
L
 -95.3%
H
0.4
25.4
|
L
H
0.4
429
|
L
H
0.4
429
|
IM Cannabis Corp |
|
12.6
|
3.1
|
L
 -6.6%
H
3.0
3.5
|
L
 -5.8%
H
2.8
3.8
|
L
 27.5%
H
2.2
3.8
|
L
 127.0%
H
1.3
7.1
|
L
 25.9%
H
1.3
7.1
|
L
 -92.2%
H
0.4
49.8
|
L
 -98.6%
H
0.4
697.8
|
L
H
0.4
697.8
|
Lifevantage Corporation |
|
159.6
|
12.7
|
L
 2.4%
H
12.2
12.8
|
L
 -6.7%
H
11.8
14.6
|
L
 2.0%
H
11.5
14.6
|
L
 -11.0%
H
9.8
15.2
|
L
 107.9%
H
6.1
27.4
|
L
 213.9%
H
3.0
27.4
|
L
 -5.2%
H
3.0
27.4
|
L
 237.2%
H
1.4
27.4
|
Mannatech Inc |
|
15.8
|
8.3
|
L
H
8.1
8.5
|
L
 -9.7%
H
8.1
9.2
|
L
 -11.6%
H
8.1
10.2
|
L
 -22.2%
H
8.1
12.0
|
L
 18.7%
H
7
16.5
|
L
 -54.7%
H
6.8
28.0
|
L
 -51.1%
H
6.8
49.1
|
L
 -52.0%
H
6.5
49.1
|
Natural Alternatives Inter... |
|
21.1
|
3.4
|
L
 0.6%
H
3.4
3.5
|
L
 3.0%
H
3.3
3.5
|
L
H
3.2
3.5
|
L
 12.5%
H
2.6
3.5
|
L
 -41.0%
H
2.6
6.9
|
L
 -66.3%
H
2.6
12.6
|
L
 -50.6%
H
2.6
19.9
|
L
 -40.5%
H
2.6
19.9
|
Nature`s Sunshine Products... |
|
276.0
|
15.0
|
L
 -5.3%
H
14.8
15.7
|
L
 -6.7%
H
14.8
16.2
|
L
 3.7%
H
13.4
16.2
|
L
 23.5%
H
11.2
16.2
|
L
 -0.5%
H
10.8
18.1
|
L
 42.7%
H
7.9
21.7
|
L
 54.8%
H
7.9
21.7
|
L
 15.1%
H
5.5
21.7
|
Paranovus Entertainment Te... |
|
56.6
|
0.8
|
L
 -7.7%
H
0.8
0.9
|
L
 -6.7%
H
0.8
1.0
|
L
 -4.6%
H
0.8
1.0
|
L
 -38.7%
H
0.8
1.4
|
L
 5%
H
0.3
1.5
|
L
 -82.5%
H
0.3
6.7
|
L
 -98.4%
H
0.3
58.4
|
L
H
0.3
122
|
PharmaCyte Biotech Inc |
|
7.6
|
1.1
|
L
 0.9%
H
1.1
1.1
|
L
 0.9%
H
1.1
1.1
|
L
 9.9%
H
1
1.2
|
L
 -7.5%
H
1
1.4
|
L
 -46.6%
H
1
2.4
|
L
 -54.1%
H
1
3.2
|
L
 -96.4%
H
1
55.5
|
L
 -99.3%
H
1
253.4
|
ProPhase Labs Inc |
|
17.4
|
0.4
|
L
H
0.4
0.4
|
L
 -4.6%
H
0.4
0.5
|
L
 27.3%
H
0.3
0.5
|
L
 40%
H
0.2
0.5
|
L
 -87.3%
H
0.2
3.5
|
L
 -96.9%
H
0.2
15.0
|
L
 -74.2%
H
0.2
16.0
|
L
 -69.6%
H
0.2
16.0
|
Qualigen Therapeutics Inc |
|
5.8
|
3.5
|
L
 -4.3%
H
3.5
3.6
|
L
 4.1%
H
3.3
4.0
|
L
 -4.9%
H
3.2
4.0
|
L
 13.9%
H
3.1
4.4
|
L
 -83.7%
H
0.1
21.4
|
L
 -98.5%
H
0.1
251.3
|
L
 -99.8%
H
0.1
3670
|
L
 -100.0%
H
0.1
586250
|
Revolution Medicines Inc |
|
7,042.8
|
37.8
|
L
 -1.5%
H
37.7
39.5
|
L
 3.1%
H
36.4
39.5
|
L
 -6.9%
H
36.4
40.7
|
L
 3.7%
H
35.4
43.7
|
L
 -16.2%
H
29.2
62.4
|
L
 61.9%
H
15.5
62.4
|
L
 48.9%
H
14.1
62.4
|
L
H
14.1
62.4
|
Upexi Inc |
|
198.6
|
5.2
|
L
 -12.8%
H
5.1
6
|
L
 59.5%
H
3.4
6.6
|
L
 -48.1%
H
2.5
11.2
|
L
 92.6%
H
2.2
22.5
|
L
 -41.6%
H
1.9
22.5
|
L
 -94.5%
H
1.9
121.6
|
L
H
1.9
187.4
|
L
H
1.9
187.4
|
Scinai Immunotherapeutics ... |
|
2.2
|
2.2
|
L
 -3.5%
H
2.2
2.4
|
L
 3.3%
H
2.1
2.5
|
L
H
2.1
2.9
|
L
 11%
H
1.9
6.2
|
L
 -45.3%
H
1.9
8.9
|
L
 -98.2%
H
1.9
129
|
L
 -100.0%
H
1.9
4989.6
|
L
 -99.5%
H
1.9
6200
|
FitLife Brands Inc |
|
123.9
|
13.2
|
L
 0.8%
H
13.0
13.3
|
L
 -4.1%
H
12.5
14.2
|
L
 -5.8%
H
12.3
14.6
|
L
 9.3%
H
11.8
16.2
|
L
 -59.7%
H
9.8
35.5
|
L
 -20.3%
H
9.8
35.5
|
L
 -20.3%
H
9.8
35.5
|
L
 -20.3%
H
9.8
35.5
|
Abivax - ADR |
|
561.7
|
8.9
|
L
 0.2%
H
8.9
9.3
|
L
 11.3%
H
7.7
9.3
|
L
 26.8%
H
5.7
9.3
|
L
 47.5%
H
5.6
9.3
|
L
 -35.1%
H
4.8
14.2
|
L
H
4.8
17.0
|
L
H
4.8
17.0
|
L
H
4.8
17.0
|
Synergy CHC Corp |
|
30.6
|
3.4
|
L
 0.3%
H
3.3
3.4
|
L
 0.9%
H
2.9
3.4
|
L
 63.5%
H
2.1
3.4
|
L
 89.9%
H
1.6
4.1
|
L
H
1.3
4.6
|
L
H
1.3
4.6
|
L
H
1.3
4.6
|
L
H
1.3
4.6
|
iBio Inc |
|
11.7
|
0.7
|
L
 -5.3%
H
0.7
0.8
|
L
 -7.7%
H
0.7
0.9
|
L
 -22.6%
H
0.7
1.0
|
L
 -10%
H
0.7
1.1
|
L
 -10%
H
0.7
1.1
|
L
 -10%
H
0.7
1.1
|
L
 -10%
H
0.7
1.1
|
L
 -10%
H
0.7
1.1
|